Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US
FREEHOLD, N.J., Dec. 18, 2023 (GLOBE NEWSWIRE) — Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ:ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced that it engaged ChtrBx, a marketing and branding company, to develop a marketing launch plan for KetoAir™ in North America, South America, the United Kingdom (UK) and the European Union (EU).
Related news for (ALBT)
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/28/25 10:00 AM
- Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders
- 24/7 Market News Snapshot 28 July, 2025 – Avalon GloboCare Corp. Common Stock (NASDAQ:ALBT)
- Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong
- 24/7 Market News Snapshot 14 July, 2025 – Avalon GloboCare Corp. Common Stock (NASDAQ:ALBT)